Pyrrolidinium,1-[[(6R,7R)-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-,inner salt

IUPAC  Name: (6R,7R)-7-[[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate   
Molecular Formula: C₁₉H₂₄N₆O₅S₂
Molecular Weight: 480.57
H bond acceptors: 11
H bond donors: 4
Freely Rotating Bonds: 7
Polar Surface Area: 169.18 Å² 
The Cas Register Number of  Cefepime is 88040-23-7.The chemical synonyms of  Cefepime (CAS NO.88040-23-7) are 1-(((6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methylpyrrolidinium hydroxide, inner salt, 7(sup 2)-(Z)-(O-methyloxime)  ; Maxipime  and  Pyrrolidinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-, hydroxide, inner salt, (6R-(6alpha,7beta(Z)))- .The molecular structure of  Cefepime (CAS NO.88040-23-7) is .

  Cefepime (CAS NO.88040-23-7) is used as pharmaceutical intermediate.

Hazard Codes: Xi
Risk Statements: 36/37/38-42/43 
R36/37/38: Irritating to eyes, respiratory system and skin. 
R42/43: May cause sensitization by inhalation and skin contact.
Safety Statements: 22-26-36/37/39 
S22: Do not breathe dust.
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. 
S36/37/39: Wear suitable protective clothing, gloves and eye/face protection.